XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues [Abstract]      
Total revenue $ 186,374 $ 77,062 $ 19,138
Operating expenses:      
Cost of sales 47,039 12,374 1,903
Research and development 102,609 106,842 131,428
Selling, general and administrative 145,880 89,066 59,220
Total operating expenses 295,528 208,282 192,551
Loss from operations (109,154) (131,220) (173,413)
Other income (expense):      
Interest income 13,735 3,857 366
Interest expense (15,105) (15,979) (17,590)
Change in fair value of derivative liability 0 906 (732)
Loss from termination of revenue interest purchase agreement (49,076) 0 0
Gain from sale of priority review voucher, net 0 0 108,000
Other (expense) income, net (2,824) 365 (582)
Net loss before provision for income taxes (162,424) (142,071) (83,951)
Provision for (benefit from) income taxes 991 (6,406) 37
Net loss $ (163,415) $ (135,665) $ (83,988)
Net loss per share:      
Basic $ (4) $ (4.01) $ (2.77)
Diluted $ (4) $ (4.02) $ (2.77)
Weighted-average shares outstanding:      
Basic 40,885,124 33,839,072 30,321,722
Diluted 40,885,124 33,982,493 30,321,722
Product      
Revenues [Abstract]      
Total revenue $ 178,874 $ 75,062 $ 3,138
License      
Revenues [Abstract]      
Total revenue $ 7,500 $ 2,000 $ 16,000